Home

 

Investor Relations

SGMO - (NASDAQ)

$5.90   + 0.03

Mar 10, 2010

2:02 PM ET



Corporate Profile

Sangamo BioSciences, Inc. is the worldwide leader in the research, development and commercialization of engineered zinc finger DNA-binding proteins for therapeutic gene regulation and therapeutic gene correction. Our technology platform has multiple applications in human therapeutics and drug discovery.

Copyright © 2010 Sangamo BioSciences, Inc.